{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:44:01Z","timestamp":1781991841740,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jctube.2025.100572","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:43:04Z","timestamp":1763635384000},"page":"100572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Latent TB treatment outcomes in patients with chronic liver disease: A retrospective cohort study"],"prefix":"10.1016","volume":"41","author":[{"given":"Lilian","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lopiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella N.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rutenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berk","family":"Madendere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amee","family":"Patrawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2025.100572_b0005","doi-asserted-by":"crossref","unstructured":"Sterling TR, Njie G, Zenner D, et al. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep 2020;69(No. RR-1):1\u201311. DOI: http:\/\/dx.doi.org\/10.15585\/mmwr.rr6901a1.","DOI":"10.15585\/mmwr.rr6901a1"},{"issue":"5","key":"10.1016\/j.jctube.2025.100572_b0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.2022.24362","article-title":"Management of Latent Tuberculosis Infection","volume":"329","author":"Kim","year":"2023","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jceh.2012.07.007","article-title":"A guide to the management of tuberculosis in patients with chronic liver disease","volume":"2","author":"Dhiman","year":"2012","journal-title":"J Clin Exp Hepatol"},{"issue":"19","key":"10.1016\/j.jctube.2025.100572_b0020","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3748\/wjg.v20.i19.5760","article-title":"Antitubercular therapy in patients with cirrhosis: challenges and options","volume":"20","author":"Kumar","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jctube.2025.100572_b0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. an official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jctube.2025.100572_b0030","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cgh.2023.11.013","article-title":"Chronic Liver Disease and Cirrhosis Mortality rates are Disproportionately increasing in Younger Women in the United States between 2000-2020","volume":"22","author":"Abboud","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cld.2021.03.009","article-title":"Epidemiology of Alcohol-Associated Liver Disease","volume":"25","author":"Han","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0040","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jctube.2025.100572_b0045","series-title":"Latent Tuberculosis Infection: a Guide for Primary Health Care Providers","author":"Centers for Disease Control and Prevention (CDC)","year":"2020"},{"issue":"9","key":"10.1016\/j.jctube.2025.100572_b0050","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"US Preventive Services Task Force","year":"2016","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"AASLD and AST Practice Guideline Committee. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jctube.2025.100572_b0060","first-page":"64","article-title":"Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease","volume":"8","author":"Edwards","year":"2023","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"issue":"26","key":"10.1016\/j.jctube.2025.100572_b0065","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3748\/wjg.v25.i26.3291","article-title":"Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation","volume":"25","author":"Silva","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103758","article-title":"Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: a comprehensive review","volume":"24","author":"Jha","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jctube.2025.100572_b0075","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/."},{"issue":"4","key":"10.1016\/j.jctube.2025.100572_b0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jinf.2010.07.009","article-title":"Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis","volume":"61","author":"Park","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jctube.2025.100572_b0085","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13513","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0090","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02048-2019","article-title":"Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs","volume":"55","author":"Ronald","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jctube.2025.100572_b0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/tid.12436","article-title":"Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes","volume":"17","author":"Grim","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jctube.2025.100572_b0100","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/TP.0000000000000133","article-title":"Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period","volume":"98","author":"Sidhu","year":"2014","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jctube.2025.100572_b0105","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/cid\/civ639","article-title":"Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates","volume":"61","author":"Tien","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2025.100572_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CLD.0000000000000003","article-title":"Latent tuberculosis infection in liver transplant patients: a review","volume":"21","author":"Cardenas","year":"2023","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jctube.2025.100572_b0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-023-02161-1","article-title":"Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients","volume":"52","author":"Lee","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.jctube.2025.100572_b0120","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221111106","article-title":"Latent Tuberculosis Infection Treatment Outcomes in an At-Risk Underserved Population in Rhode Island","volume":"13","author":"Verma","year":"2022","journal-title":"J Prim Care Community Health"},{"issue":"11","key":"10.1016\/j.jctube.2025.100572_b0125","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/liv.13892","article-title":"Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes","volume":"38","author":"Thomson","year":"2018","journal-title":"Liver Int"},{"issue":"suppl_1","key":"10.1016\/j.jctube.2025.100572_b0130","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/ofid\/ofw172.1860","article-title":"Latent Tuberculosis Treatment Cascade in Chronic Kidney Disease patients: the Vancouver Experience","volume":"3","author":"Harris","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.jctube.2025.100572_b0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:19:19Z","timestamp":1764721159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579425000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S2405579425000634"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100572","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent TB treatment outcomes in patients with chronic liver disease: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100572"}}